Apex Biotechnology Corp. (1733)
Market Closed
15 Oct, 05:30 AM
TWSE TWSE Primary NT$
29. 85
-0.25
-0.8306%
NT$
3.07B Market Cap
- P/E Ratio
8% Div Yield
131,386 Volume
- Eps
NT$ 30.1
Previous Close Want to track 1733 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Apex Biotechnology Corp. (1733) Statistics
Valuation metrics
Market Cap 3.07B
Enterprise value 2.45B
Trailing P/E (ttm) 16.03
Forward P/E -
PEG ratio 0.97
Price/Sales (ttm) 1.63
Price/Book (mrq) 1.65
Enterprise Value/Revenue 1.31
Enterprise Value/EBITDA 10.8
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 108.95K
Average volume (90 days) 165.62K
Price summary
52-Week low 28
52-Week high 38.7
Beta -
50-Day moving average 30.97
200-Day moving average 30.24
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 1.3
Trailing annual dividend yield 0.0427%
5-Year annual dividend yield -
Payout ratio 0.63
Dividend Date 9 Jul 2026
Ex-Dividend Date 9 Jun 2026
Last split factor 1:1
Last split Date 1 Jul 2009
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.1%
Operating margin 0.09%
Operational effectiveness
Return on assets 0.07%
Return on equity 0.1%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 18.58
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 1.9
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 8.11
Total debt (mrq) -
Total Debt/Equity (mrq) 0.08
Current ratio (mrq) 3.11%
Book value per share (mrq) 18.51
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
